ArticleBiosensors2025
Photoplethysmography Feature Extraction for Non-Invasive Glucose Estimation by Means of MFCC and Machine Learning Techniques.
Article in Biosensors, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Diabetes Mellitus is considered one of the most widespread diseases in the world. Traditional glucose monitoring devices carry discomfort and risks associated with the frequent extraction of blood from users. The present article proposes a noninvasive glucose estimation system based on the application of Mel Frequency Cepstral Coefficients (MFCCs) for the characterization of photoplethysmographic signals (PPG). Two variants of the MFCC feature extraction methods are evaluated along with three machine learning techniques for the development of an effective regression function for the estimation of glucose concentration. A comparison between the performance of the algorithms revealed that the best combination achieved a mean absolute error of 9.85 mg/dL and a correlation of 0.94 between the estimated concentration and the real glucose values. Similarly, 99.53% of the validation samples were distributed within zones A and B of the Clarke Error Grid Analysis. The proposed system achieves levels of correlation comparable to analogous technologies that require earlier calibration for its operation, which indicates a strong potential for the future use of the algorithm as an alternative to invasive monitoring devices.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.